EX-10.2 4 d341683dex102.htm INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENT INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENT BY AND BETWEEN CONOCOPHILLIPS AND PHILLIPS 66 DATED AS OF APRIL 26, 2012 Page INTELLECTUAL PROPERTY ASSIGNMENT...Intellectual Property Assignment and License Agreement • May 5th, 2020 • Delaware
THIS INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENT made and entered into effective as of April 26, 2012 (this “Agreement”), is by and between ConocoPhillips, a Delaware corporation (“ConocoPhillips”), and Phillips 66, a Delaware corporation and wholly-owned subsidiary of ConocoPhillips (“Phillips 66”) (the “Parties”). Capitalized terms used herein and not otherwise defined shall have the respective meanings assigned to them in Article I or in that certain Separation and Distribution Agreement between ConocoPhillips and Phillips 66 dated as of April 26, 2012 (the “Separation and Distribution Agreement”).
INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENTIntellectual Property Assignment and License Agreement • August 7th, 2014 • Demand Media Inc. • Services-computer processing & data preparation • California
This INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENT (“Agreement”) is made and entered into effective as of July 30, 2014 (the “Effective Date”), by and between Demand Media, Inc., a Delaware corporation (“Demand Media”), and Rightside Operating Co., a Delaware corporation (“Rightside Opco”). Demand Media and Rightside Opco are each referred to herein as a “Party” and collectively as the “Parties.”
INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENTIntellectual Property Assignment and License Agreement • May 5th, 2020
This Intellectual Property Assignment and License Agreement (this “Agreement”) is entered into on this 27th day of March, 2009 by and among Suzhou EZTripMart Business Services Co., Ltd., a wholly foreign-owned enterprise established in the People’s Republic of China (“China” or “PRC) with its registered office at Suite 201, 1 Venture House, Modern Industrial Square Phase II, 333 Xing Pu Road, Suzhou Industrial Park, Suzhou, China (“EZT” or “Grantor”); and Shanghai EZTripMart Travel Agency Co., Ltd., a limited liability company incorporated in the PRC with its registered office at 13/F, 200 Taicang Road, Shanghai, China (“Company” or “Grantee”) (Each of EZT and Company is herein referred to as a “Party” and collective as the “Parties”).
INTELLECTUAL PROPERTY ASSIGNMENT AND LICENCE AGREEMENT DATED 7TH FEBRUARY, 2005 VERNALIS DEVELOPMENT LIMITED and RHINOPHARMA LTD.Intellectual Property Assignment and License Agreement • April 3rd, 2017 • Verona Pharma PLC • Pharmaceutical preparations
EX-10.10 16 dex1010.htm RESTATED AND AMENDED INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENT RESTATED AND AMENDED INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENTIntellectual Property Assignment and License Agreement • May 5th, 2020
This Restated and Amended Intellectual Property Assignment and License Agreement (the “Agreement”) is entered into on July 30, 1998 (the “Amendment Date”) and made effective as of July 30, 1997 (the “Effective Date”) by and between THERMAGE, a California corporation, having its principal place of business at 905 San Ramon Valley Blvd., #110, Danville, California 94526 (“Assignee” or the “Company”), and EDWARD W. KNOWLTON, residing at 5478 Blackhawk Drive, Danville, California 94506 (“Assignor” or “Knowlton”).
INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENTIntellectual Property Assignment and License Agreement • December 22nd, 2011 • Marlborough Software Development Holdings Inc. • Services-prepackaged software • Massachusetts
INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENTIntellectual Property Assignment and License Agreement • March 15th, 2012 • Preferred Apartment Communities Inc • Real estate investment trusts
This Intellectual Property Assignment and License Agreement (this "Agreement") is made and entered into this 14th day of March, 2012 (the "Effective Date") by and between Preferred Apartment Advisors, LLC ("Licensor") and Preferred Apartment Communities, Inc. ("Licensee").
SUPPLEMENTAL AGREEMENT REGARDING INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENTIntellectual Property Assignment and License Agreement • March 18th, 2013 • Optimer Pharmaceuticals Inc • Pharmaceutical preparations
This Supplemental Agreement Regarding Intellectual Property Assignment and License Agreement (the “Supplement”) is made and effective as of October 19, 2012 (the “Effective Date”) by and between Optimer Pharmaceuticals, Inc., a Delaware corporation (“Optimer”), and Optimer Biotechnology, Inc., a Taiwan corporation (“OBI”) to supplement, restate and/or amend, as applicable, that certain Intellectual Property Assignment and License Agreement dated October 30, 2009 between Optimer and OBI (the “Intellectual Property Agreement”). Except as otherwise expressly provided herein, capitalized terms used but not defined herein shall have their respective meanings set forth in the Intellectual Property Agreement.
GENEXINE, INC. AND TASGEN BIO-TECH (TIANJIN) CO., LTD. INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENT DATED October 16th, 2015Intellectual Property Assignment and License Agreement • October 4th, 2019 • I-Mab • Pharmaceutical preparations
INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENTIntellectual Property Assignment and License Agreement • June 21st, 2021 • Applied UV, Inc. • Electric lighting & wiring equipment • Delaware
This intellectual property assignment and license agreement (this “Agreement”) is entered into as of January 1, 2021 (the “Effective Date”), by and between KES SCIENCE & TECHNOLOGY, INC., a Georgia corporation having its address at 3625 Kennesaw North Industrial Parkway, Kennesaw, Georgia 30144 (“KES”), KES AIR TECHNOLOGIES, LLC, a Georgia limited liability company having its address at 3625 Kennesaw North Industrial Parkway, Kennesaw, Georgia 30144 (“Kes Air”), and AKIDA HOLDING, LLC, a Florida limited liability company having its address at 2300 Marshpoint Road Suite 202, Neptune Beach, Florida 32266 (“Akida”). KES, Kes Air and Akida are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
Exhibit 2.3 INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENT THIS INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENT ("Agreement"), dated as of this day of December, 1997, is made by and between Raytheon Company, a Delaware corporation...Intellectual Property Assignment and License Agreement • January 13th, 1998 • Fairchild Semiconductor Corp • Semiconductors & related devices • Massachusetts
INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENTIntellectual Property Assignment and License Agreement • October 31st, 2007 • Vitesse Semiconductor Corp • Semiconductors & related devices • California
THIS INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENT (this “Agreement”) is entered into as of October 29, 2007, by and between Vitesse Semiconductor Corporation, a Delaware corporation (“Vitesse”), and Maxim Integrated Products, Inc., a Delaware corporation (“Buyer”). For the purposes of this Agreement, Buyer expressly includes all of its subsidiaries and Affiliate entities. All capitalized terms used but not defined in this Agreement will have the meanings assigned to them in the Asset Purchase Agreement (as defined herein).
INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENTIntellectual Property Assignment and License Agreement • November 3rd, 2009 • Optimer Pharmaceuticals Inc • Pharmaceutical preparations • California
THIS INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENT (the “Agreement”) is made and entered into effective as of October 30, 2009 (the “Effective Date”) by and between OPTIMER PHARMACEUTICALS, INC., a Delaware corporation (“Optimer”), and OPTIMER BIOTECHNOLOGY, INC., a Taiwan corporation (“OBI”).
INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENTIntellectual Property Assignment and License Agreement • December 22nd, 2011 • Marlborough Software Development Holdings Inc. • Services-prepackaged software • Massachusetts
FORM OF INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENTIntellectual Property Assignment and License Agreement • December 14th, 2010 • Preferred Apartment Communities Inc • Real estate investment trusts
This Intellectual Property Assignment and License Agreement (this “Agreement”) is made and entered into this ___ day of December, 2010 (the “Execution Date”), to be effective as of _____________, 2010 (the Effective Date”) by and between Preferred Apartment Advisors, LLC (“Licensor”) and Preferred Apartment Communities, Inc. (“Licensee”).
INTRODUCTIONIntellectual Property Assignment and License Agreement • November 28th, 2006 • Motient Corp • Communications services, nec • New York
GENEXINE, INC. AND TASGEN BIO-TECH (TIANJIN) CO., LTD. INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENT DATED October 16th, 2015Intellectual Property Assignment and License Agreement • September 5th, 2019 • I-Mab • Pharmaceutical preparations
ContractIntellectual Property Assignment and License Agreement • March 16th, 2007 • Skyterra Communications Inc • Communications services, nec • New York
SECOND AMENDED AND RESTATED INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENT (the “Second Amended and Restated Agreement”), dated November 21, 2006 and effective as of October 01, 2006 (the “Effective Date”) by and between ATC Technologies, LLC, a Delaware limited liability company (“Technologies”) and TerreStar Networks Inc., a Delaware corporation (“TerreStar”).
INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENT by and between AGENUS INC. and MINK THERAPEUTICS, INC. dated as of September 10, 2021Intellectual Property Assignment and License Agreement • September 14th, 2021 • MiNK Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENT (this “Agreement”) is entered into as of September 10, 2021 (the “Effective Date”) by and between, on the one hand, AGENUS INC., a Delaware corporation having its principal place of business at 3 Forbes Road Lexington, Massachusetts 02421 (“Agenus”), and, on the other hand, MINK THERAPEUTICS, INC., a Delaware corporation having its principal place of business at 149 Fifth Avenue Suite 500 New York, New York 10010 (“MiNK”), and solely for purposes of Section 5.1, Agenus Switzerland and Agenus UK Ltd, both of which are wholly owned subsidiaries of Agenus, and AgenTus Therapeutics SA and AgenTus Therapeutics Ltd, both of which are wholly owned subsidiaries of MiNK. Agenus and MiNK are referred to individually as a “Party” and collectively as the “Parties.”
